MONOVISC®: A Single Injection, Lightly Cross-linked High Molecular Weight Hyaluronic Acid

A One-Injection OA Treatment

Monovisc is a single injection viscosupplement utilized to treat the joint pain caused by osteoarthritis. It is comprised of highly purified, partially cross-linked sodium hyaluronate (NaHA) in a phosphate buffered saline solution, and it is both biocompatible and resorbable.

With just one injection, Monovisc may provide pain relief that lasts for up to 6 months.1

Monovisc is the only non-animal sourced hyaluronic acid (HA) single injection treatment approved for use in the United States, and it delivers the maximum dose of HA (88mg) currently available in any single injection treatment.